Initiative creates new resource to support and accelerate early-stage therapeutics companiesParexel forms inaugural ...

MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the launch of its ai² Future Labs program in partnership with The University of ...

In this Q&A, Ingenza CEO Nick Challoner, discusses how CRDMOs must evolve to help biotech companies accelerate development, ...

MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the ...

T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...

Seoul National University Hospital will use its first independent BIO convention booth to help five S. Korean biotech ...

Filippo Mulinacci joined Araris Biotech in 2022 as its chief business officer. In March, the oncology company, based in Zurich, Switzerland, was acquired by Taiho Pharma, based in Tokyo, as part of a ...

Chinese drug makers are increasingly relying on overseas licensing deals to reach global markets amid growing geopolitical ...

India's biotech sector is evolving towards innovation, yet funding challenges hinder the growth of competitive global ...

Dr. Afshin Safavi is a founder, councilman, consultant, board member, entrepreneur, and investor in biotechnology, pharmaceutical, animal health, technology, and real-estate sectors with multi-billion ...